APA (7th ed.) Citation

F, W., E, T., GJ, B., R, Ž., L, G., K, S., . . . L, F. (2025). PBPK Modeling to Support Bioavailability and Bioequivalence Assessment in Pediatric Populations. Pharmaceutical research, 42(5), 847. https://doi.org/10.1007/s11095-025-03846-y

Chicago Style (17th ed.) Citation

F, Wu, et al. "PBPK Modeling to Support Bioavailability and Bioequivalence Assessment in Pediatric Populations." Pharmaceutical Research 42, no. 5 (2025): 847. https://doi.org/10.1007/s11095-025-03846-y.

MLA (9th ed.) Citation

F, Wu, et al. "PBPK Modeling to Support Bioavailability and Bioequivalence Assessment in Pediatric Populations." Pharmaceutical Research, vol. 42, no. 5, 2025, p. 847, https://doi.org/10.1007/s11095-025-03846-y.